Gurgaon, Haryana, India
Across my career, I’ve consistently solved complex commercial situations, either to build the operating engine behind growth or to directly own and deliver the P&L. At Takeda India, I spent 6 years on the Country Leadership Team, first 5 as the Head of Business Operations, building the commercial backbone of the affiliate: corporate strategy, performance governance, CRM transformation, launch and commercial excellence, incentive architecture, and portfolio strategy. I then moved into full P&L ownership as Business Unit Head for Immunology & GI, a ₹500Cr+ specialty franchise with a 40-member national team, 150+ distributors and 500+ institutional accounts. Delivered above market growth in a supply-constrained environment , while strengthening channel discipline, productivity, and margin integrity. My differentiation: I’ve built the commercial systems that drive performance, and I’ve run the business accountable for outcomes. That means I understand where growth breaks, how to fix it, and how to scale it in complex, regulated markets. Earlier in my career: built institutional Oncology key account management model at Roche India and helped establish the Bariatric & Metabolic surgery category at Johnson & Johnson. MBA from Michigan Ross. Specialties: Oncology, Metabolic, Rare and genetic diseases, Immunology, GI, Vaccines.
Led one of Takeda India's largest specialty BUs, full P&L accountability across Immunology and GI, covering sales, marketing, operations, and execution governance. Delivered consistent above-market revenue growth; maintained 100% sales incentive attainment throughout tenure. Led 40-person national organisation across sales, marketing, and support functions; built performance culture achieving 95% employee engagement, highest in the affiliate. Directed portfolio and capital allocation across 500+ institutional accounts (100+ govt., 400+ private); defended ~90% of key accounts through patient-priority filters and demand forecasting. Rationalized distributor network via 80/20 analytics; redeployed capacity into underpenetrated markets, driving significant growth in East and West regions. Improved sales force productivity 20–25% per rep through CRM-driven call planning and structured engagement sequencing.
Served on the Country Leadership Team as strategic partner to the GM, owning India's commercial architecture, operating model, and long-range growth agenda across 5 therapy areas. Designed affiliate-wide performance governance framework linking KPIs to P&L outcomes; improved decision speed and cross-functional execution discipline. Drove CRM transformation (Veeva): improved forecast accuracy from ~44% variance to ~25%; achieved >90% field adoption. Recognized with industry-wide Veeva Hero Award 2024. Institutionalized Launch Excellence across 30+ assets in 5 therapy areas; delivered 100% on-time launches, building a ~$300M 10-year projected pipeline. Led Takeda–Shire post-acquisition integration in India: operating model redesign, portfolio harmonization, and governance alignment. Business Operations function recognized as Best Commercial Function FY21 and FY22; received GM Special Appreciation Awards FY23 and FY24.
Spearheaded post-merger integration planning across portfolio, processes, and execution governance for combined India entity. Built business cases for new product launches across priority therapy areas.
Established Roche India’s Key Account Management vertical, securing approvals at global, regional, and local levels. Developed & executed commercial strategies across largest private hospital chain, driving business growth and strengthening partnerships.
Developed strategic marketing initiatives to enhance engagement with key oncology opinion leaders. Designed and executed market penetration strategies, expanding Roche’s oncology footprint.
Managed corporate reputation & PR strategies for top-tier technology clients. Led P&L responsibility for major accounts, driving revenue growth and profitability. Spearheaded new business initiatives, expanding the company’s client base in the tech sector.
Developed innovative marketing & brand strategies for the Metabolic & Bariatric (M&B) business. Led India’s first-ever D2C awareness campaign for J&J Med Devices, driving category expansion. Collaborated with global & local cross-functional teams, translating international insights into regional growth strategies.